rawpixel / iStockphoto.com
Trademarks covering Bayer’s branded Aspirin were at the centre of an appeal dismissed by the EU General Court yesterday.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
EU General Court, Bayer, Uni-Pharma, trademark opposition, likelihood of confusion, branded drugs, distinctiveness, reputation, figurative trademark appeal